Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review

Stock Information for Beneficient

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Beneficient

Presenting on Emerging Growth Conference 91 Day 2 on April 2; Register to live stream
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th
Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream
Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026
Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.